Brain nucleoside recycling

Metabolomics

Volumn 9, Issue 2, 2013, Pages 271-279

  Ipata, Piero Luigi ^a   Balestri, Francesco ^a   Tozzi, Maria Grazia ^a   Camici, Marcella ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Brain ectonucleotidases; Extracellular nucleotide catabolism; Intracellular brain nucleosides; Nucleoside homeostasis; Purine salvage; Pyrimidine salvage

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; CYTIDINE; CYTIDINE TRIPHOSPHATE; GUANOSINE; GUANOSINE TRIPHOSPHATE; INOSINE; NUCLEOSIDE; NUCLEOSIDE TRIPHOSPHATE; PURINE NUCLEOSIDE; PYRIMIDINE NUCLEOSIDE; URIDINE; URIDINE TRIPHOSPHATE;

BRAIN LEVEL; BRAIN METABOLISM; CELL LEVEL; CELL METABOLISM; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM DISEASE; CYTOSOL; DEPHOSPHORYLATION; DRUG MECHANISM; EXTRACELLULAR SPACE; HUMAN; INTRACELLULAR SPACE; MEMBRANE BINDING; MOLECULAR INTERACTION; NONHUMAN; NUCLEIC ACID METABOLISM; NUCLEOTIDE METABOLISM; REVIEW;

EID: 84875489795     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-012-0457-x     Document Type: Review

References (78)

1. Abbracchio, M. P., Burnstock, G., Verkhratsky, A., & Zimmermann, H. (2009). Purinergic signalling in the nervous system: An overview. Trends in Neurosciences, 32, 19-29.
2. Allegrini, S., Scaloni, A., Careddu, M. G., Cuccu, G., D'ambrosio, C., Pesi, R., et al. (2004). Mechanistic studies on bovine cytosolic 5′-nucleotidase II, an enzyme belonging to the HAD superfamily. European Journal of Biochemistry, 271, 4881-4891.
3. Allsop, J., & Watts, R. W. (1983). Purine de novo synthesis in liver and developing rat brain, and the effect of some inhibitors of purine nucleotide interconversion. Enzyme, 30, 172-180.
4. Allsop, J., & Watts, R. W. (1984). Purine synthesis and salvage in brain and liver. Advances in Experimental Medicine and Biology, 165, 21-26.
5. Amadio, S., Apolloni, S., D'Ambrosi, N., & Volontè, C. (2011). Purinergic signalling at the plasma membrane: A multipurpose and multidirectional mode to deal with amyotrophic lateral sclerosis and multiple sclerosis. Journal of Neurochemistry, 116, 796-805.
6. Aymerich, I., Pastor-Anglada, M., & Casado, F. J. (2004). Long term endocrine regulation of nucleoside transporters in rat intestinal epithelial cells. Journal of General Physiology, 124(505-512), 2004.
7. Baldwin, S. A., Beal, P. R., Yao, S. Y., King, A. E., Cass, C. E., & Young, J. D. (2004). The equilibrative nucleoside transporter family, SLC29. Pflugers Archiv, 447, 735-743.
8. Balestri, F., Barsotti, C., Lutzemberger, L., Camici, M., & Ipata, P. L. (2007a). Key role of uridine kinase and uridine phosphorylase in the homeostatic regulation of purine and pyrimidine salvage in brain. Neurochemistry International, 51, 517-523.
9. Balestri, F., Giannecchini, M., Sgarrella, F., Carta, M. C., Tozzi, M. G., & Camici, M. (2007b). Purine and pyrimidine nucleosides preserve human astrocytoma cell adenylate energy charge under ischemic conditions. Neurochemistry International, 50(517-523), 2007.
10. Bar-Even, A., Flamholz, A., Noor, E., Milo, R. (2012). Rethinking glycolysis: on the biochemical logic of metabolic pathways. Nature Chemical Biology, 8(6), 509-517.
11. Barsotti, C., & Ipata, P. L. (2004). Metabolic regulation of ATP breakdown and of adenosine production in rat brain extracts. International Journal of Biochemistry & Cell Biology, 36, 2214-2225.
12. Barsotti, C., Tozzi, M. G., & Ipata, P. L. (2002). Purine and pyrimidine salvage in whole rat brain. Utilization of ATP-derived ribose-1-phosphate and 5-phosphoribosyl-1-pyrophosphate generated in experiments with dialyzed cell-free extracts. Journal of Biological Chemistry, 277, 9865-9869.
13. Becker, M. A. (2001a). Phosphoribosylpyrophosphate synthetase and the regulation of phosphoribosylpyrophosphate production in human cells. Progress in Nucleic Acid Research, 169, 115-148.
14. Becker M. A. (2001b). Hyperuricemia and gout. In: C. R. Scriver, A. L. Beaudet, W. S. Sly, D. Valle (Eds.), B. K. Childs, W. Kinzler, B. Vegelstein (assoc. Eds.), The metabolic and molecular basis of inherited disease, Vol. 2. Mc-Grow-Hill, New York, pp. 2513-2535.
15. Bester, A. C., Roniger, M. Y., Oren, S., Im, M. M., Sarni, D., Chaoat, M., et al. (2011). Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell, 145, 435-446.
16. Bianchi, V., & Spychala, J. (2003). Mammalian 5′-nucleotidases. Journal of Biological Chemistry, 278, 46195-46198.
17. Boison, D. (2007). Adenosine-based cell therapies approaches for pharmacoresistant epilepsies. Neurodegenerative Diseases, 4(28-33), 2007.
18. Boison, D. (2011). Modulators of nucleoside metabolism in the therapy of brain diseases. Current Topics in Medicinal Chemistry, 11, 1068-1086.
19. Bourget, P. A., & Trembly, G. C. (1972). Pyrimidine biosynthesis in rat brain. Journal of Neurochemistry, 19, 1617-1624.
20. Bowser, D. N., & Kahkh, S. (2007). Vesicular ATP is the predominant cause of intracellular calcium waves in astrocytes. Journal of General Physiology, 129, 485-491.
21. Burnstock, G. (2000). P2X receptors in sensory neurons. British Journal of Anaesthesia, 84, 476-488.
22. Burnstock, G. (2007). Purine and pyrimidine receptors. Cellular Molecular Life Science, 64, 1471-1483.
23. Cansev, M. (2006). Uridine and cytidine in the brain: their transport and utilization. Brain Research Reviews, 52, 389-397.
24. Cao, D., & Pizzorno, G. (2004). Uridine phosphorylase: An important enzyme in pyrimidine metabolism and fluoropyrimidine activation. Drugs Today, (Barcelona, Spain: 1998), 5, 431-443.
25. Cheng, N., Payne, R. C., & Traut, T. W. (1986). Regulation of uridine kinase. Evidence for a regulatory site. Journal of Biological Chemistry, 261, 13006-13012.
26. Correale, J., & Villa, A. (2008). Cellular elements of the blood brain barrier. Neurochemical Research, 34, 2067-2077.
27. Cunha, R. A. (2001). Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochemistry International, 2, 107-125.
28. Dobolyi, A., Juhasz, G., Kovacs, Z., & Kardos, J. (2011). Uridine function in the central nervous system. Current Topic in Medicinal Chemistry, 11, 1058-1067.
29. Egeblad, L., Welin, M., Flodin, S., Graslund, S., Wang, L., Balzarini, J., et al. (2012). Pan-pathway based interaction profiling of FDA-approved nucleoside and nucleobase analogs with enzymes of the human nucleotide metabolism. PLoS ONE, 7(5), e37724. doi: 10. 1371/journal. pone. 0037724.
30. Giannecchini, M., Matteucci, M., Pesi, R., Sgarrella, F., Tozzi, M. G., & Camici, M. (2005). Uptake and utilization of nucleosides for energy repletion. International Journal of Biochemistry and Cell Biology, 37, 797-808.
31. Gray, J. H., Owen, R. P., & Giacomini, K. M. (2004). The concentrative nucleoside transporter family, SLC28. Pflugers Archiv, 447, 728-734.
32. Hunsucker, S. A., Mitchell, B. S., & Spychala, J. (2005). 5′-Nucleotidases as regulators of nucleotides and drug metabolism. Pharmacology & Therapeutics, 107, 1-30.
33. Ipata, P. L. (2011). Origin, utilization, and recycling of nucleosides in the central nervous system. Advances in Physiology Education, 35, 342-346.
34. Ipata, P. L., Balestri, F., Camici, M., & Tozzi, M. G. (2011a). Molecular mechanisms of nucleoside recycling in the brain. International Journal of Biochemistry & Cell Biology, 43, 140-145.
35. Ipata, P. L., Barsotti, C., Tozzi, M. G., Camici, M., & Balestri, F. (2010). Metabolic interplay between intra- and extra-cellular uridine metabolism via an ATP driver uridine-UTP cycle in brain. International Journal of Biochemistry & Cell Biology, 42, 932-937.
36. Ipata, P. L., Camici, M., Micheli, V., & Tozzi, M. G. (2011b). Metabolic network of nucleosides in the brain. Current Topics in Medicinal Chemistry, 11, 909-922.
37. James, S., & Richardson, P. J. (1993). Production of adenosine from extracellular ATP at the striatal cholinergic synapse. Journal of Neurochemistry, 60(1), 219-227.
38. Jones, M. E. (1980). Pyrimidine nucleotide biosynthesis in animals: genes, enzymes, and regulation of UMP biosynthesis. Annual Review of Biochemistry, 49, 253-280.
39. Kovács, Z., Dobolyi, A., Juhasz, G., & Kelesi, K. A. (2010). Nucleoside map of the human central nervous system. Neurochemical Research, 35, 452-464.
40. Kovács, Z., Juhasz, G., Palkovits, M., Dobolyi, A., & Kelesi, K. A. (2011). Area, age and gender dependence of the nucleoside system in the brain: a review of current literature. Current Topics in Medicinal Chemistry, 11, 1012-1033.
41. Lai, K. M., & Wong, P. C. L. (1991). Metabolism of extracellular adenine nucleotides by cultured rat brain astrocytes. Journal of Neurochemistry, 57, 1510-1515.
42. Latini, S., & Pedata, F. (2001). Adenosine in the central nervous system: Release mechanisms and extracellular concentrations. Journal of Neurochemistry, 79, 463-484.
43. Lazarowski, E. R., & Bucher, R. C. (2001). UTP as an extracellular signaling molecule. News in Physiological Sciences, 16, 1-5.
44. Lecca, D., & Ceruti, S. (2008). Uracil nucleotides: From metabolic intermediates to neuroprotection and inflammation. Biochemical Pharmacology, 75, 1869-1881.
45. Mallol, J., & Bozal, J. (1983). Modification of 5′-nucleotidase activity by divalent cations and nucleotides. Journal of Neurochemistry, 40, 1205-1211.
46. Markowitz, C. E., Spitsin, S., Zimmerman, V., Jacobs, D., Udupa, J. K., Kooper, D. C., et al. (2009). The treatment of multiple sclerosis with inosine. Journal of Alternative Complementary Medicine, 15, 619-625.
47. Mascia, L., Cappiello, M., Cherri, S., & Ipata, P. L. (2000). In vitro recycling of alpha-D-ribose 1-phosphate for the salvage of purine bases. Biochimica Biophysica Acta, 1474, 70-74.
48. Micheli, V., Camici, M., Tozzi, M. G., Ipata, P. L., Sestini, S., Bertelli, M., et al. (2011). Neurological disorders of purine and pyrimidine metabolism. Current Topics in Medicinal Chemistry, 11, 923-947.
49. Nagai, K., Nagasawa, K., & Fujimoto, S. (2005). Transport mechanisms for adenosine and uridine in primary-cultured rat cortical neurons and astrocytes. Biochemical and Biophysical Research Communications, 334, 1343-1350.
50. Nagasawa, K., Escartin, C., & Swanson, R. A. (2009). Astrocyte cultures exhibit P2X7 receptor channel opening in the absence of exogenous ligands. Glia, 57, 622-633.
51. Nagasawa, K., Kawasaki, K., Tanaka, A., Nagai, K., & Fujimoto, S. (2007). Characterization of guanine and guanosine transport in primary cultured rat astrocytes and neurons. Glia, 55, 1397-1404.
52. Neary, J. T., & Zimmermann, H. (2009). Trophic functions of nucleotides in the central nervous system. Trends in Neurosciences, 32, 189-198.
53. Nyhan, W. L. (2005). Disorders of purine and pyrimidine metabolism. Molecular Genetics and Metabolism, 86, 25-33.
54. Okuda, H., Higashi, Y., Nishida, K., Fujimoto, S., & Nagasawa, K. (2010). Contribution of P2X7 receptors to adenosine uptake by cultured mouse astrocytes. Glia, 58, 1757-1765.
55. Pankratov, Y., Lalo, U., Verkhratsky, A., & North, R. A. (2006). Vesicular release of ATP at central synapses. Pflugers Archiv, 452, 589-597.
56. Pankratov, Y., Lalo, U., Verkhratsky, A., & North, R. A. (2007). Quantal release of ATP in mouse cortex. Journal of General Physiology, 129, 257-265.
57. Parkinson, F. E., Damaraju, V. L., Graham, K., Yao, S. Y. M., Baldwin, S. A., Cass, C. E., et al. (2011). Molecular biology of nucleoside transporters and their distribution and functions in the brain. Current Topics in Medicinal Chemistry, 11, 948-972.
58. Parpura, V., Baker, V. J., Jeraz, M., & Zorec, R. (2010). Regulated exocytosis in astrocytic signal integration. Neurochemistry International, 57, 451-459.
59. Rathbone, M. P., Pilutti, L., Caciagli, F., & Jiang, S. (2008). Neurotrophic effects of extracellular guanosine. Nucleosides, Nucleotides & Nucleic Acids, 27, 666-672.
60. Rittiner, J. E., Korboukh, I., Hull-Ride, E. A., Jin, J., Janzen, W. P., Frye, S. V., et al. (2012). AMP is an adenosine A1 receptor agonist. Journal of Biological Chemistry, 40, 5301-5309.
61. Robergs, R. A., Ghiasvand, F., Parker, D. (2004). Biochemistry of exercise-induced metabolic acidosis. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 287(3), R502-R516.
62. Schachman, H. K. (2000). Still looking for the ivory tower. Annual Review of Biochemistry, 69, 1-29.
63. Spatz, M. (2010). Past and recent BBB studies with particular emphasis on changes in ischemic brain edema: dedicated to the memory of Dr. Igor Klatzo. Acta Neurochirurgica Supplementum, 106, 21-27.
64. Suzuki, N. N., Koizumi, K., Fukushima, M., Matsuda, A., & Inagaki, F. (2004). Structural basis for the specificity, catalysis, and regulation of human uridine-cytidine kinase. Structure, 12, 751-764.
65. Tavares, R. G., Schmidt, A. P., Tasca, C. I., & Souza, D. O. (2009). Quinolinic acid-induced seizures stimulate glutamate uptake into synaptic vesicles from rat brain: effects prevented by guanine-based purines. Neurochemical Research, 33, 97-102.
66. Traut, T. W. (1994). Physiological concentrations of purines and pyrimidines. Molecular and Cellular Biochemistry, 140, 1-22.
67. van der Beek, E. M., & Kamphuis, P. J. The potential role of nutritional components in the management of Alzheimer's Disease. The European Journal of Pharmacology, 585(1), 197-207.
68. Volonté, C., & D'Ambrosi, N. (2008). Membrane compartments and purinergic signaling: The purinome, a complex interplay among ligands, degrading enzymes, receptors and transporters. FEBS Journal, 276, 318-329.
69. Wang, L., Karlsson, A., Arnér, E. S. J., & Eriksson, S. (1993). Substrate specificity of mitochondrial 2′-deoxyguanosine kinase. Efficient phosphorylation of 2-chlorodeoxyadenosine. Journal of Biological Chemistry, 268, 22847-22852.
70. Wink, M. R., Braganhol, E., Tamajusuku, A. S. K., Lenz, G., Zerbini, L. F., Libermann, T. A., et al. (2006). Nucleoside triphosphate diphosphohydrolase-2 (NTPDase2/CD39L1) is the dominant ectonucleotidase expressed by rat astrocytes. Neuroscience, 138, 421-432.
71. Wurtman, R. J., Cansev, M., Sakamoto, T., & Ulus, I. H. (2009). Use of phosphatide precursors to promote synaptogenesis. Annual Review of Nutrition, 29, 59-87.
72. Wurtman, R. J., Hefti, H., & Melamed, E. (1980). Precursor control of neurotransmitter synthesis. Pharmacological Reviews, 32, 315-335.
73. Wurtman, R. J., Sakamoto, T., & Ulus, I. H. (2008). Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses. Alzheimer's & Dementia, 4, S153-S168.
74. Wyngaarden, J. B. (1976). Regulation of purine biosynthesis and turnover. Enzyme Regulation, 14, 25-42.
75. Wyngaarden, J. B., & Holmes, E. W., Jr. (1977). Molecular nature of enzyme regulation in purine biosynthesis. Ciba Foundation Symposium, 48, 43-64.
76. Zimmermann, H. (1992). 5′-Nucleotidase: Molecular structure and functional aspects. Biochemical Journal, 285, 345-365.
77. Zimmermann, H. (1996). Biochemistry, localization and functional roles of ecto-nucleotidases in the nervous system. Progress in Neurobiology, 49, 589-618.
78. Zimmermann, H. (2006). Ecto-nucleotidases in the nervous system. In Novartis foundation symposium 276 purinergic signalling in neuron-glial interaction (pp. 113-128). Wiley.